Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Microscopic polyangiitis.

Lucy Smyth1, Gillian Gaskin, Charles D Pusey

  • 1Renal Section, Division of Medicine, Imperial College London, Hammersmith Hospital, London, United Kingdom.

Seminars in Respiratory and Critical Care Medicine
|August 10, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The multiple autoantibodies in anti-GBM disease.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association·2025
Same author

Anti-glomerular basement membrane disease-treatment standard.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association·2025
Same author

Kidney Complement Immunohistochemistry in Thrombotic Microangiopathy Subtypes.

Kidney international reports·2025
Same author

Long-Term Follow-Up of a Glucocorticoid Minimizing Regimen for the Treatment of Severe Antineutrophil Cytoplasmic Autoantibody-Associated Vasculitis.

Kidney international reports·2025
Same author

The effects of plasma exchange and glucocorticoids on early kidney function among patients with ANCA-associated vasculitis in the PEXIVAS trial.

Kidney international·2024
Same author

Unexpected Delayed Incursion of Highly Pathogenic Avian Influenza H5N1 (Clade 2.3.4.4b) Into the Antarctic Region.

Influenza and other respiratory viruses·2024
Same journal

Monographic Issue on New Concepts in Acute Exacerbations of COPD.

Seminars in respiratory and critical care medicine·2026
Same journal

Bidirectional Clinical Interactions among Exacerbations and Comorbidities in COPD: A Narrative Review.

Seminars in respiratory and critical care medicine·2026
Same journal

Radiological Approach to Severe Respiratory Infections and Pulmonary Complications in Immunocompromised Patients.

Seminars in respiratory and critical care medicine·2026
Same journal

Two Sides of the Same Smoke: Decoding Respiratory Bronchiolitis-Associated Interstitial Lung Disease and Alveolar Macrophage Pneumonia.

Seminars in respiratory and critical care medicine·2026
Same journal

Role of Vaccination in the Prevention of ECOPD.

Seminars in respiratory and critical care medicine·2026
Same journal

Acute Exacerbation of Chronic Obstructive Pulmonary Disease: Pharmacological Treatment of AECOPD New Perspectives.

Seminars in respiratory and critical care medicine·2026
See all related articles

Microscopic polyangiitis is a systemic vasculitis. Treatment involves immunosuppression, with plasma exchange showing promise for severe kidney disease and alveolar hemorrhage.

Area of Science:

  • Nephrology
  • Rheumatology
  • Immunology

Background:

  • Microscopic polyangiitis (MPA) is a small-to-medium vessel systemic vasculitis.
  • It characteristically presents with necrotizing glomerulonephritis and can manifest as a pulmonary-renal syndrome.
  • Distinguishing MPA from granulomatous conditions like Wegener's is crucial.

Purpose of the Study:

  • To summarize the key features, etiology, and current management strategies for microscopic polyangiitis.
  • To highlight the role of antineutrophil cytoplasm antibodies (ANCA) in MPA pathogenesis.
  • To discuss the efficacy of various treatment modalities, including plasma exchange.

Main Methods:

  • Review of existing literature on microscopic polyangiitis.
  • Analysis of diagnostic criteria and differentiating features from similar vasculitides.

Related Experiment Videos

  • Evaluation of current and emerging therapeutic approaches.

    • Main Results:

    • MPA is associated with antineutrophil cytoplasm antibodies (ANCA), often targeting myeloperoxidase (MPO) or proteinase 3 (PR3).
    • Treatment typically involves cyclophosphamide and steroids for remission induction, followed by maintenance immunosuppression.
    • Plasma exchange demonstrates effectiveness in severe renal disease and alveolar hemorrhage, potentially improving renal function recovery.

    Conclusions:

    • MPA requires prompt diagnosis and management to improve patient outcomes.
    • ANCA positivity, particularly MPO-ANCA, may be associated with a lower relapse rate.
    • Ongoing research aims to develop more effective and less toxic therapies for microscopic polyangiitis.